Security key
004225108
ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)
CUSIP: 004225108
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 150,041,187
- Total 13F value
- $6,188,429,775
- Share change
- -1,541,129
- Put/Call ratio
- 125%
- SEC-reported price per share
- $41.25
- Number of holders
- 262
- Value change
- -$100,187,840
- Number of buys
- 146
- Number of sells
- 161
- Shares outstanding
- 170,504,990
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
262
Top holders
10
ACAD full security history
Ownership snapshot
Full 13F holder table
ACADIA PHARMACEUTICALS INC SEC filings
ACADIA PHARMACEUTICALS INC company facts
Broader feeds
Ownership snapshot
Top reported holders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 25%
Showing 1-6 of 15 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 25%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
25%
FMR LLC
12%
PRICE T ROWE ASSOCIATES INC /MD/
6.7%
VANGUARD GROUP INC
6.3%
BlackRock Finance, Inc.
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
Company
|
25%
|
$2,031,115,000
41,904,586 shares
|
— | 30 Jun 2020 |
| FMR LLC |
13F
Company
|
12%
|
$1,007,706,000
20,790,304 shares
|
— | 30 Jun 2020 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
6.7%
|
$549,736,000
11,341,786 shares
|
— | 30 Jun 2020 |
| VANGUARD GROUP INC |
13F
Company
|
6.3%
|
$516,759,000
10,661,419 shares
|
— | 30 Jun 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
4.5%
|
$376,022,000
7,757,846 shares
|
— | 30 Jun 2020 |
| Janus Henderson Group Ltd. |
13F
Company
|
2.3%
|
$189,517,000
3,909,963 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
262
Shares
150,041,187
Rows available
262
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
292
Q3 2020 holders
262
Holder diff
-30
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|